Kent Hoskins

5.7k total citations · 1 hit paper
74 papers, 2.2k citations indexed

About

Kent Hoskins is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Kent Hoskins has authored 74 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 32 papers in Genetics and 18 papers in Cancer Research. Recurrent topics in Kent Hoskins's work include BRCA gene mutations in cancer (27 papers), Global Cancer Incidence and Screening (20 papers) and Cancer Risks and Factors (15 papers). Kent Hoskins is often cited by papers focused on BRCA gene mutations in cancer (27 papers), Global Cancer Incidence and Screening (20 papers) and Cancer Risks and Factors (15 papers). Kent Hoskins collaborates with scholars based in United States, Canada and Philippines. Kent Hoskins's co-authors include Fergus J. Couch, Judy E. Garber, Barbara L. Weber, Gregory S. Calip, Melody Cobleigh, M. Anne Blackwood, Arupa Ganguly, Timothy R. Rebbeck, Jill E. Stopfer and Lisa Jablon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Kent Hoskins

67 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer

1997 506 citations Fergus J. Couch, Barbara L. Weber et al. profile →

Peers

Countries citing papers authored by Kent Hoskins

Since Specialization

Citations

This map shows the geographic impact of Kent Hoskins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent Hoskins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent Hoskins more than expected).

Fields of papers citing papers by Kent Hoskins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent Hoskins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent Hoskins. The network helps show where Kent Hoskins may publish in the future.

Co-authorship network of co-authors of Kent Hoskins

This figure shows the co-authorship network connecting the top 25 collaborators of Kent Hoskins. A scholar is included among the top collaborators of Kent Hoskins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent Hoskins. Kent Hoskins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiplex imaging reveals novel patterns of MRTFA/B activation in the breast cancer microenvironment 2025 ·Journal of Translational Medicine ·S. Wilk, Kihak Lee, (unknown), (unknown), (unknown), Virgilia Macias, Elizabeth L. Wiley, Zhengjia Chen, Xinyi Liu, Xiaowei Wang, Maria Sverdlov, Kent Hoskins, Ekrem Emrah Er	1
2	Risk-reducing salpingo-oophorectomy among diverse patients with BRCA mutations at an urban public hospital: a mixed methods study 2024 ·BMJ Open ·(unknown), (unknown), Tara Maga, (unknown), (unknown), Kent Hoskins, Kimberly Richardson, Quetzal A. Class, (unknown)	1
3	Are We the Problem? A Call to Action for Addressing Institutional Challenges to Engaging Community Partners in Research 2024 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sarah Khan, (unknown), (unknown), Anne Marie Murphy, (unknown), (unknown), (unknown), Kent Hoskins, Vida Henderson, (unknown)	2
4	32P Genomic risk classification and whole transcriptome analysis of HR+/HER2- post-partum breast cancers: A FLEX sub study 2024 ·ESMO Open ·Virginia F. Borges, Elena Shagisultanova, Joyce O’Shaughnessy, Adam Brufsky, Reshma Mahtani, Kent Hoskins, Hannah M. Linden, (unknown), (unknown), (unknown), William Audeh	1
5	TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer 2023 ·Oncogene ·Rakesh Sathish Nair, Sandeep Kumar, Subhasis Das, Sunil Kumar Singh, (unknown), Gautam Sondarva, (unknown), Subhash C. Sinha, Rui Xiong, Laura J. Bloem, Kent Hoskins, Gregory R. J. Thatcher, Basabi Rana, Ajay Rana	14
6	Physical functioning, frailty and risks of locally-advanced breast cancer among older women 2022 ·The Breast ·(unknown), (unknown), Naomi Y. Ko, (unknown), Kent Hoskins, Brian C.‐H. Chiu, Gregory S. Calip	3
7	Identification of exosome protein biomarkers in patients with advanced hormone receptor-positive breast cancer treated with palbociclib and tamoxifen. 2022 ·Journal of Clinical Oncology ·Ziwei Zhang, (unknown), (unknown), (unknown), (unknown), Cristina I. Truica, Anne Blaes, (unknown), (unknown), Lauren Green, Menggang Yu, Deborah Toppmeyer, Ruth O’Regan, Kari B. Wisinski, Oana C. Danciu, Gayatry Mohapatra, Kent Hoskins, Yu Gao	2
8	Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity 2022 ·Breast Cancer Research and Treatment ·Hsiao‐Ching Huang, (unknown), (unknown), (unknown), Colin C. Hubbard, Kent Hoskins, Naomi Y. Ko, Jenny S. Guadamuz, Gregory S. Calip	16
9	Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer 2022 ·Cancer Causes & Control ·Gregory S. Calip, (unknown), Colin C. Hubbard, (unknown), In-Young Lee, Jifang Zhou, (unknown), Debanjali Mitra, Naomi Y. Ko, Kent Hoskins, Ernest H. Law	2
10	Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk 2022 ·BMC Health Services Research ·Vida Henderson, Jessica M. Madrigal, (unknown), (unknown), Jennifer Newsome, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ravneet Kaur, (unknown), Tara Maga, Zo Ramamonjiarivelo, (unknown), Robert A. Winn, Karriem S. Watson, Angela Odoms‐Young, Kent Hoskins	6
11	Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race 2021 ·The Breast ·Jifang Zhou, (unknown), Naomi Y. Ko, Kent Hoskins, (unknown), (unknown), Colin C. Hubbard, Debanjali Mitra, Gregory S. Calip, Ernest H. Law	6
12	Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity 2020 ·Proceedings of the National Academy of Sciences ·Sandeep Kumar, Sunil Kumar Singh, Navin Viswakarma, Gautam Sondarva, Rakesh Sathish Nair, Periannan Sethupathi, Subhash C. Sinha, Rajyasree Emmadi, Kent Hoskins, Oana C. Danciu, Gregory R. J. Thatcher, Basabi Rana, Ajay Rana	17
13	Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling 2019 ·Cell Death and Disease ·(unknown), (unknown), (unknown), (unknown), Jeremiah J. Zartman, Simon Kaja, Claire M. Wells, (unknown), Kimberly J. Curtis, (unknown), Laurie E. Littlepage, Glen L. Niebur, Kent Hoskins, Michael I. Nishimura, Saverio Gentile	60
14	Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities 2017 ·Breast Cancer Research and Treatment ·Garth H. Rauscher, Abigail Silva, Heather Pauls, Jonna Frasor, Marcelo G. Bonini, Kent Hoskins	32
15	The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database 2016 ·Cancer Causes & Control ·(unknown), Caryn E. Peterson, Katherine C. Brewer, (unknown), Faith G. Davis, Kent Hoskins, Charlotte E. Joslin	9
16	Selenium levels in human breast carcinoma tissue are associated with a common polymorphism in the gene for SELENOP (Selenoprotein P) 2016 ·Journal of Trace Elements in Medicine and Biology ·Dede N. Ekoue, Sofia Zaichick, Klara Valyi‐Nagy, Matthew J. Picklo, (unknown), Kent Hoskins, Michael Warso, Marcelo G. Bonini, Alan M. Diamond	18
17	Associations between diabetes medication use and risk of second breast cancer events and mortality 2015 ·Cancer Causes & Control ·Gregory S. Calip, Onchee Yu, Kent Hoskins, Denise M. Boudreau	27
18	The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago 2014 ·Gynecologic Oncology ·Charlotte E. Joslin, Katherine C. Brewer, Faith G. Davis, Kent Hoskins, Caryn E. Peterson, Heather Pauls	20
19	Individual Breast Cancer Risk Assessment in Underserved Populations: Integrating Empirical Bioethics and Health Disparities Research 2012 ·Journal of Health Care for the Poor and Underserved ·Emily E. Anderson, Kent Hoskins	11
20	Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer 1994 ·Nature Genetics ·Lucio H. Castilla, Fergus J. Couch, Michael R. Erdos, Kent Hoskins, (unknown), Judy E. Garber, Jeff Boyd, Matthew Lubin, (unknown), Lawrence C. Brody, Francis S. Collins, Barbara L. Weber	307

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact